Cargando…
Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators
The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229223/ https://www.ncbi.nlm.nih.gov/pubmed/25390337 http://dx.doi.org/10.1371/journal.pone.0112614 |
_version_ | 1782344103728513024 |
---|---|
author | Arora, Rohit Bhushan, Sakshi Kumar, Rakesh Mannan, Rahul Kaur, Pardeep Singh, Amrit Pal Singh, Bikram Vig, Adarsh P. Sharma, Deepika Arora, Saroj |
author_facet | Arora, Rohit Bhushan, Sakshi Kumar, Rakesh Mannan, Rahul Kaur, Pardeep Singh, Amrit Pal Singh, Bikram Vig, Adarsh P. Sharma, Deepika Arora, Saroj |
author_sort | Arora, Rohit |
collection | PubMed |
description | The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and γ-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin. |
format | Online Article Text |
id | pubmed-4229223 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-42292232014-11-18 Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators Arora, Rohit Bhushan, Sakshi Kumar, Rakesh Mannan, Rahul Kaur, Pardeep Singh, Amrit Pal Singh, Bikram Vig, Adarsh P. Sharma, Deepika Arora, Saroj PLoS One Research Article The toxicity induced by 7, 12-dimethylbenz(α)anthracene (DMBA) has been widely delineated by a number of researchers. This potent chemical damages many internal organs including liver, by inducing the production of reactive oxygen species, DNA-adduct formation and affecting the activities of phase I, II, antioxidant and serum enzymes. Glucosinolate hydrolytic products like isothiocyanates (ITCs) are well known for inhibiting the DNA-adduct formation and modulating phase I, II enzymes. Sulforaphane is ITC, currently under phase trials, is readily metabolized and inter-converted into erucin upon ingestion. We isolated erucin from Eruca sativa (Mill.) Thell. evaluated its hepatoprotective role in DMBA induced toxicity in male wistar rats. The rats were subjected to hepatic damage by five day regular intraperitoneal doses of DMBA. At the end of the protocol, the rats were euthanized, their blood was collected and livers were processed. The liver homogenate was analyzed for phase I (NADPH-cytochrome P450 reductase, NADH-cytochrome b5 reductase, cytochrome P450, cytochrome P420 and cytochrome b5), phase II (DT diaphorase, glutathione-S-transferase and γ-glutamyl transpeptidase) and antioxidant enzymes (superoxide dismutase, catalase, guaiacol peroxidise, ascorbate peroxidise, glutathione reductase and lactate dehydrogenase). The level of thiobarbituric acid reactive substances, lipid hydroperoxides, conjugated dienes and reduced glutathione in the liver homogenate was also analyzed. The serum was also analyzed for markers indicating hepatic damage (alkaline phosphatase, serum glutamic oxaloacetic transaminase, serum glutamic pyruvic transaminase, direct bilirubin and total bilirubin). Erucin provided significant protection against DMBA induced damage by modulating the phase I, II and antioxidant enzymes. The histological evaluation of liver tissue was also conducted, which showed the hepatoprotective role of erucin. Public Library of Science 2014-11-12 /pmc/articles/PMC4229223/ /pubmed/25390337 http://dx.doi.org/10.1371/journal.pone.0112614 Text en © 2014 Arora et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Arora, Rohit Bhushan, Sakshi Kumar, Rakesh Mannan, Rahul Kaur, Pardeep Singh, Amrit Pal Singh, Bikram Vig, Adarsh P. Sharma, Deepika Arora, Saroj Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title | Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title_full | Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title_fullStr | Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title_full_unstemmed | Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title_short | Hepatic Dysfunction Induced by 7, 12-Dimethylbenz(α)anthracene and Its Obviation with Erucin Using Enzymatic and Histological Changes as Indicators |
title_sort | hepatic dysfunction induced by 7, 12-dimethylbenz(α)anthracene and its obviation with erucin using enzymatic and histological changes as indicators |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4229223/ https://www.ncbi.nlm.nih.gov/pubmed/25390337 http://dx.doi.org/10.1371/journal.pone.0112614 |
work_keys_str_mv | AT arorarohit hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT bhushansakshi hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT kumarrakesh hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT mannanrahul hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT kaurpardeep hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT singhamritpal hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT singhbikram hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT vigadarshp hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT sharmadeepika hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators AT arorasaroj hepaticdysfunctioninducedby712dimethylbenzaanthraceneanditsobviationwitherucinusingenzymaticandhistologicalchangesasindicators |